The Nifty Pharma index was trading slightly lower at 22,529.20, down 0.23 per cent, reflecting mixed sentiment across ...
Global pharma major, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced ...
The U.S. FDA has approved Lupin's Dapagliflozin Tablets, 5 mg and 10 mg, as bioequivalent to Farxiga (R) for the indications in the approved labeling.
BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States following the approval for its Abbreviated ...
Lupin announced the launch of Dapagliflozin Tablets in strengths of 5 mg and 10 mg in the United States, following approval of its abbreviated new drug application (ANDA) by the U.S. Food and Drug ...
7don MSN
Lupin shares to be in focus on Thursday as USFDA approves Dapagliflozin and Metformin tablets
Lupin's shares are expected to attract investor attention as the company received U.S. FDA approval for Dapagliflozin and ...
Hosted on MSN
Baltimore-founded drug maker, pharma start-up accuse each other of stealing trade secrets
A leading drugmaker is embroiled in a legal battle with a biopharmaceutical startup, with each claiming the other has stolen trade secrets related to generic inhalers for asthma and other chronic ...
Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith ...
Lupin said Nanomi inked definitive agreements to acquire the minority shareholding from certain existing shareholders of MPPI to acquire 1.1 crore shares, which account for 43.38% of its total ...
The integration of VISUfarma has significantly expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health, and ...
Catalyst Pharmaceuticals (NASDAQ:CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with Lupin Pharmaceuticals, putting an end to a patent lawsuit. The lawsuit was in ...
Global pharma major Lupin Limited (Lupin) today announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results